Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00029027.xml
Download PDF
J Pediatr Genet 2015; 04(03): 177-186
DOI: 10.1055/s-0035-1564571
DOI: 10.1055/s-0035-1564571
Review Article
Ultra-Rare Syndromes: The Example of Rubinstein–Taybi Syndrome
Further Information
Publication History
24 April 2015
10 May 2015
Publication Date:
28 September 2015 (online)
Abstract
Rubinstein–Taybi syndrome (RSTS) is a rare, congenital, plurimalformative, and neurodevelopmental disorder. Clinical diagnosis can be complicated by the heterogeneous clinical presentation and the lack of a consensus list of diagnostic criteria, and it is confirmed by molecular tests in approximately 55 to 78% of cases. The etiology is partially known with mutations in two functionally related genes: CREBBP and EP300. Notwithstanding the knowledge on clinical, genetic, and allelic heterogeneity, no clear genotype–phenotype correlation has yet been established. Standardized guidelines for the management of pediatric patients are available and therapy for RSTS patients is currently only symptomatic. In this article, several clinic and genetic aspects of RSTS are critically reviewed.
-
References
- 1 Rubinstein JH, Taybi H. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 1963; 105: 588-608
- 2 Padfield CJ, Partington MW, Simpson NE. The Rubinstein-Taybi syndrome. Arch Dis Child 1968; 43 (227) 94-101
- 3 Petrij F, Giles RH, Dauwerse HG , et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995; 376 (6538) 348-351
- 4 Roelfsema JH, White SJ, Ariyürek Y , et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76 (4) 572-580
- 5 Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 2004; 23 (3) 278-284
- 6 Stef M, Simon D, Mardirossian B , et al. Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients. Eur J Hum Genet 2007; 15 (8) 843-847
- 7 Spena S, Milani D, Rusconi D , et al. Insights into genotype-phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein-Taybi syndrome patients. Clin Genet 2014;
- 8 Rusconi D, Negri G, Colapietro P , et al. Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire. Hum Genet 2015; 134 (6) 613-626
- 9 Woods SA, Robinson HB, Kohler LJ, Agamanolis D, Sterbenz G, Khalifa M. Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome. Am J Med Genet A 2014; 164A (1) 251-258
- 10 Negri G, Milani D, Colapietro P , et al. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Clin Genet 2015; 87 (2) 148-154
- 11 Bounakis N, Karampalis C, Sharp H, Tsirikos AI. Surgical treatment of scoliosis in Rubinstein-Taybi syndrome type 2: a case report. J Med Case Reports 2015; 9: 10
- 12 Solomon BD, Bodian DL, Khromykh A , et al. Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome. Am J Med Genet A 2015; 167A (5) 1111-1116
- 13 Chiang PW, Lee NC, Chien N, Hwu WL, Spector E, Tsai AC. Somatic and germ-line mosaicism in Rubinstein-Taybi syndrome. Am J Med Genet A 2009; 149A (7) 1463-1467
- 14 Padfield CJ, Partington MW, Simpson NE. The Rubinstein-Taybi syndrome. Arch Dis Child 1968; 43 (227) 94-101
- 15 Verma IC. Rubinstein Taybi syndrome. Case report. Indian Pediatr 1970; 7 (12) 672-674
- 16 Cotsirilos P, Taylor JC, Matalon R. Dominant inheritance of a syndrome similar to Rubinstein-Taybi. Am J Med Genet 1987; 26 (1) 85-93
- 17 Bartsch O, Kress W, Kempf O, Lechno S, Haaf T, Zechner U. Inheritance and variable expression in Rubinstein-Taybi syndrome. Am J Med Genet A 2010; 152A (9) 2254-2261
- 18 Tajir M, Fergelot P, Lancelot G , et al. Germline mosaicism in Rubinstein-Taybi syndrome. Gene 2013; 518 (2) 476-478
- 19 Yagihashi T, Kosaki K, Okamoto N , et al. Age-dependent change in behavioral feature in Rubinstein-Taybi syndrome. Congenit Anom (Kyoto) 2012; 52 (2) 82-86
- 20 Beets L, Rodríguez-Fonseca C, Hennekam RC. Growth charts for individuals with Rubinstein-Taybi syndrome. Am J Med Genet A 2014; 164A (9) 2300-2309
- 21 Milani D, Manzoni FM, Pezzani L , et al. Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management. Ital J Pediatr 2015; 41 (1) 4
- 22 Blum RW. Transition to adult health care: setting the stage. J Adolesc Health 1995; 17 (1) 3-5
- 23 Bartsch O, Labonté J, Albrecht B , et al. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome. Am J Med Genet A 2010; 152A (1) 181-184
- 24 Roelfsema JH, Peters DJ. Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med 2007; 9 (23) 1-16
- 25 Wieczorek D, Bartsch O, Lechno S , et al. Two adults with Rubinstein-Taybi syndrome with mild mental retardation, glaucoma, normal growth and skull circumference, and camptodactyly of third fingers. Am J Med Genet A 2009; 149A (12) 2849-2854
- 26 Nakai K, Yoneda K, Moriue T, Kubota Y. Striate palmoplantar keratoderma in a patient with Rubinstein-Taybi syndrome. J Eur Acad Dermatol Venereol 2009; 23 (3) 333-335
- 27 van Genderen MM, Kinds GF, Riemslag FCC, Hennekam RCM. Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol 2000; 84 (10) 1177-1184
- 28 Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet 1995; 56 (1) 112-115
- 29 Stevens CA, Pouncey J, Knowles D. Adults with Rubinstein-Taybi syndrome. Am J Med Genet A 2011; 155A (7) 1680-1684
- 30 Levitas AS, Reid CS. Rubinstein-Taybi syndrome and psychiatric disorders. J Intellect Disabil Res 1998; 42 (Pt 4) 284-292
- 31 Hennekam RC, Stevens CA, Van de Kamp JJ. Etiology and recurrence risk in Rubinstein-Taybi syndrome. Am J Med Genet Suppl 1990; 6: 56-64
- 32 Bloch-Zupan A, Stachtou J, Emmanouil D, Arveiler B, Griffiths D, Lacombe D. Oro-dental features as useful diagnostic tool in Rubinstein-Taybi syndrome. Am J Med Genet A 2007; 143A (6) 570-573
- 33 Zucconi M, Ferini-Strambi L, Erminio C, Pestalozza G, Smirne S. Obstructive sleep apnea in the Rubinstein-Taybi syndrome. Respiration 1993; 60 (2) 127-132
- 34 Choi HS, Yu JJ, Kim YH, Ko JK, Park IS. Pulmonary hypertension due to obstructive sleep apnea in a child with Rubinstein-Taybi syndrome. Korean J Pediatr 2012; 55 (6) 212-214
- 35 Peñaranda A, Cerón M. Rubinstein-Taybi syndrome and mixed bilateral hypoacousia case report. Otol Neurotol 2007; 28 (4) 501-503
- 36 Naimi DR, Munoz J, Rubinstein J, Hostoffer Jr RW. Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections. Allergy Asthma Proc 2006; 27 (3) 281-284
- 37 Marabotti A, Giannecchini G, Cariello A , et al. Stenosis of the lachrymal system in Rubinstein-Taybi syndrome. Ophthalmologica t 2002; 216 (4) 272-276
- 38 van Genderen MM, Kinds GF, Riemslag FC, Hennekam RC. Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol 2000; 84 (10) 1177-1184
- 39 Robson MJ, Brown LM, Sharrard WJ. Cervical spondylolisthesis and other skeletal abnormalities in Rubinstein-Taybi syndrome. J Bone Joint Surg Br 1980; 62 (3) 297-299
- 40 Yamamoto T, Kurosawa K, Masuno M , et al. Congenital anomaly of cervical vertebrae is a major complication of Rubinstein-Taybi syndrome. Am J Med Genet A 2005; 135 (2) 130-133
- 41 Marzuillo P, Grandone A, Luongo C , et al. Brain magnetic resonance in the routine management of Rubinstein-Taybi syndrome (RTS) can prevent life-threatening events and neurological deficits. Am J Med Genet A 2014; 164A (8) 2129-2132
- 42 Rubinstein JH. Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957-1988. Am J Med Genet Suppl 1990; 6: 3-16
- 43 Wójcik C, Volz K, Ranola M , et al. Rubinstein-Taybi syndrome associated with Chiari type I malformation caused by a large 16p13.3 microdeletion: a contiguous gene syndrome?. Am J Med Genet A 2010; 152A (2) 479-483
- 44 Parsley L, Bellus G, Handler M, Tsai AC. Identical twin sisters with Rubinstein-Taybi syndrome associated with Chiari malformations and syrinx. Am J Med Genet A 2011; 155A (11) 2766-2770
- 45 Giussani C, Selicorni A, Fossati C , et al. The association of neural axis and craniovertebral junction anomalies with scoliosis in Rubinstein-Taybi syndrome. Childs Nerv Syst 2012; 28 (12) 2163-2168
- 46 Marzuillo P, Grandone A, Coppola R , et al. Novel cAMP binding protein-BP (CREBBP) mutation in a girl with Rubinstein-Taybi syndrome, GH deficiency, Arnold Chiari malformation and pituitary hypoplasia. BMC Med Genet 2013; 14: 28
- 47 Barson AJ. Proceedings: Rubinstein-Taybi syndrome. Arch Dis Child 1974; 49 (6) 495
- 48 Agarwal R, Aggarwal R, Kabra M, Deorari AK. Dandy-Walker malformation in Rubinstein-Taybi syndrome: a rare association. Clin Dysmorphol 2002; 11 (3) 223-224
- 49 Tanaka T, Ling BC, Rubinstein JH, Crone KR. Rubinstein-Taybi syndrome in children with tethered spinal cord. J Neurosurg 2006; 105 (4, Suppl): 261-264
- 50 Hennekam RCM. Rubinstein-Taybi syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. 3rd ed. Hoboken, NJ: Wiley-Blackwell; 2010: 705-715
- 51 Stevens CA, Bhakta MG. Cardiac abnormalities in the Rubinstein-Taybi syndrome. Am J Med Genet 1995; 59 (3) 346-348
- 52 Hanauer D, Argilla M, Wallerstein R. Rubinstein-Taybi syndrome and hypoplastic left heart. Am J Med Genet 2002; 112 (1) 109-111
- 53 Fischer S, Bäzner H, Henkes H. Cervical artery dissection in a young patient with Rubinstein-Taybi syndrome. Clin Neuroradiol 2013; 23 (1) 41-44
- 54 Ishizaka S, Sou G, Morofuji Y , et al. Dissecting aneurysm of the anterior cerebral artery with Rubinstein-Taybi syndrome—a case report [in Japanese]. Brain Nerve 2010; 62 (10) 1083-1088
- 55 Isidor B, Podevin G, Camby C , et al. Rubinstein-Taybi syndrome and Hirschsprung disease in a patient harboring an intragenic deletion of the CREBBP gene. Am J Med Genet A 2010; 152A (7) 1847-1848
- 56 Olson DP, Koenig RJ. Thyroid function in Rubinstein-Taybi syndrome. J Clin Endocrinol Metab 1997; 82 (10) 3264-3266
- 57 Kurtoglu S, Akcakus M, Gunes T, Cetin N, Topaloglu N. Congenital hypothyroidism associated with Rubinstein-Taybi syndrome. J Pediatr Endocrinol Metab 2003; 16 (3) 457-459
- 58 Tornese G, Marzuillo P, Pellegrin MC , et al. A case of Rubinstein-Taybi syndrome associated with growth hormone deficiency in childhood. Clin Endocrinol (Oxf) 2015;
- 59 Bayle P, Bazex J, Lamant L, Lauque D, Durieu C, Albes B. Multiple perforating and non perforating pilomatricomas in a patient with Churg-Strauss syndrome and Rubinstein-Taybi syndrome. J Eur Acad Dermatol Venereol 2004; 18 (5) 607-610
- 60 van de Kar AL, Houge G, Shaw AC , et al. Keloids in Rubinstein-Taybi syndrome: a clinical study. Br J Dermatol 2014; 171 (3) 615-621
- 61 Papathemeli D, Schulzendorff N, Kohlhase J, Göppner D, Franke I, Gollnick H. Pilomatricomas in Rubinstein-Taybi syndrome. J Dtsch Dermatol Ges 2015; 13 (3) 240-242
- 62 Siraganian PA, Rubinstein JH, Miller RW. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989; 17 (6) 485-491
- 63 de Kort E, Conneman N, Diderich K. A case of Rubinstein-Taybi syndrome and congenital neuroblastoma. Am J Med Genet A 2014; 164A (5) 1332-1333
- 64 Ihara K, Kuromaru R, Takemoto M, Hara T. Rubinstein-Taybi syndrome: a girl with a history of neuroblastoma and premature thelarche. Am J Med Genet 1999; 83 (5) 365-366
- 65 Bourdeaut F, Miquel C, Richer W , et al. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma. Pediatr Blood Cancer 2014; 61 (2) 383-386
- 66 Evans G, Burnell L, Campbell R, Gattamaneni HR, Birch J. Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma. Med Pediatr Oncol 1993; 21 (6) 433-434
- 67 Skousen GJ, Wardinsky T, Chenaille P. Medulloblastoma in patient with Rubinstein-Taybi syndrome. Am J Med Genet 1996; 66 (3) 367
- 68 Taylor MD, Mainprize TG, Rutka JT, Becker L, Bayani J, Drake JM. Medulloblastoma in a child with Rubenstein-Taybi syndrome: case report and review of the literature. Pediatr Neurosurg 2001; 35 (5) 235-238
- 69 Johannesen EJ, Williams T, Miller DC, Tuller E. Synchronous ovarian and endometrial carcinomas in a patient with Rubinstein-Taybi syndrome: a case report and literature review. Int J Gynecol Pathol 2015; 34 (2) 132-135
- 70 Hennekam RC, Baselier AC, Beyaert E , et al. Psychological and speech studies in Rubinstein-Taybi syndrome. Am J Ment Retard 1992; 96 (6) 645-660
- 71 Wiley S, Swayne S, Rubinstein JH, Lanphear NE, Stevens CA. Rubinstein-Taybi syndrome medical guidelines. Am J Med Genet A 2003; 119A (2) 101-110
- 72 Schorry EK, Keddache M, Lanphear N , et al. Genotype-phenotype correlations in Rubinstein-Taybi syndrome. Am J Med Genet A 2008; 146A (19) 2512-2519
- 73 Hood RL, Lines MA, Nikkel SM , et al; FORGE Canada Consortium. Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. Am J Hum Genet 2012; 90 (2) 308-313
- 74 Campeau PM, Kim JC, Lu JT , et al. Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome. Am J Hum Genet 2012; 90 (2) 282-289
- 75 Simpson MA, Deshpande C, Dafou D , et al. De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome. Am J Hum Genet 2012; 90 (2) 290-294
- 76 Chen X, Xu H, Yuan P , et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133 (6) 1106-1117
- 77 Scolnick DM, Chehab NH, Stavridi ES , et al. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res 1997; 57 (17) 3693-3696
- 78 Yan W, Liu S, Xu E , et al. Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8. Oncogene 2013; 32 (5) 599-609
- 79 Coupry I, Roudaut C, Stef M , et al. Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome. J Med Genet 2002; 39 (6) 415-421
- 80 Bentivegna A, Milani D, Gervasini C , et al. Rubinstein-Taybi syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med Genet 2006; 7: 77
- 81 Bartsch O, Schmidt S, Richter M , et al. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 2005; 117 (5) 485-493
- 82 Bartholdi D, Roelfsema JH, Papadia F , et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J Med Genet 2007; 44 (5) 327-333
- 83 Imaizumi K, Kuroki Y. Rubinstein-Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3). Am J Med Genet 1991; 38 (4) 636-639
- 84 Tommerup N, van der Hagen CB, Heiberg A. Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3). Am J Med Genet 1992; 44 (2) 237-241
- 85 Allis CD, Berger SL, Cote J , et al. New nomenclature for chromatin-modifying enzymes. Cell 2007; 131 (4) 633-636
- 86 Park E, Kim Y, Ryu H, Kowall NW, Lee J, Ryu H. Epigenetic mechanisms of Rubinstein-Taybi syndrome. Neuromolecular Med 2014; 16 (1) 16-24
- 87 Wang J, Weaver IC, Gauthier-Fisher A , et al. CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain. Dev Cell 2010; 18 (1) 114-125
- 88 Oike Y, Hata A, Mamiya T , et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 1999; 8 (3) 387-396
- 89 Foley P, Bunyan D, Stratton J, Dillon M, Lynch SA. Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am J Med Genet A 2009; 149A (5) 997-1000
- 90 Gervasini C, Castronovo P, Bentivegna A , et al. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints. Genomics 2007; 90 (5) 567-573
- 91 Bartsch O, Rasi S, Delicado A , et al. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome. Hum Genet 2006; 120 (2) 179-186
- 92 Shim JH, Greenblatt MB, Singh A , et al. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice. J Clin Invest 2012; 122 (1) 91-106
- 93 Vecsey CG, Hawk JD, Lattal KM , et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 2007; 27 (23) 6128-6140
- 94 Lopez-Atalaya JP, Gervasini C, Mottadelli F , et al. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. J Med Genet 2012; 49 (1) 66-74